vigabatrin has been researched along with Optic Nerve Diseases in 4 studies
Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to evaluate the relationship between the area of isopters obtained using semi-automated kinetic perimetry (SKP) and Vigabatrin dosage in epilepsy patients with pretreatment baseline examination during 2-years of the follow-up." | 3.80 | Relationship between the area of isopters and Vigabatrin dosage during two years of observation. ( Brzozowska, A; Jedrych, M; Juenemann, AG; Koss, MJ; Ksiazek, K; Ksiazek, P; Maciejewski, R; Nowomiejska, K; Rejdak, K; Rejdak, R; Schiefer, U; Zarnowski, T, 2014) |
| "Subjects were older than 18 years, 129 with vigabatrin-treated epilepsy (vigabatrin-exposed group) and 87 individuals with epilepsy never treated with vigabatrin (nonexposed group)." | 3.78 | Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals. ( Acheson, JF; Clayton, LM; de Haan, GJ; Devile, M; Punte, T; Sander, JW; Sisodiya, SM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nowomiejska, K | 1 |
| Jedrych, M | 1 |
| Brzozowska, A | 1 |
| Rejdak, K | 1 |
| Zarnowski, T | 1 |
| Koss, MJ | 1 |
| Ksiazek, K | 1 |
| Ksiazek, P | 1 |
| Maciejewski, R | 1 |
| Juenemann, AG | 1 |
| Schiefer, U | 1 |
| Rejdak, R | 1 |
| Clayton, LM | 1 |
| Devile, M | 1 |
| Punte, T | 1 |
| de Haan, GJ | 1 |
| Sander, JW | 1 |
| Acheson, JF | 1 |
| Sisodiya, SM | 1 |
| Depasse, F | 1 |
| Crofts, K | 1 |
| Brennan, R | 1 |
| Kearney, P | 1 |
| O'Connor, G | 1 |
1 review available for vigabatrin and Optic Nerve Diseases
| Article | Year |
|---|---|
[Epilepsy and Sabril].
Topics: Adult; Algorithms; Animals; Anticonvulsants; Child; Epilepsy; Humans; Optic Nerve Diseases; Retinal | 2007 |
3 other studies available for vigabatrin and Optic Nerve Diseases
| Article | Year |
|---|---|
Relationship between the area of isopters and Vigabatrin dosage during two years of observation.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Female; Follow-Up Studies; Human | 2014 |
Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals.
Topics: Adult; Anticonvulsants; Cross-Sectional Studies; Epilepsy; Female; Humans; Male; Middle Aged; Nerve | 2012 |
Vigabatrin-induced optic neuropathy.
Topics: Anticonvulsants; Child; Female; gamma-Aminobutyric Acid; Humans; Optic Nerve Diseases; Vigabatrin | 1997 |